Business Wire

PMI to Commit Additional USD 200 Million to Corporate Venture Capital Activities of PM Equity Partner

Share

Philip Morris International Inc. (PMI) (NYSE: PM) today announced its plans to dedicate a further USD 200 million to minority investments in early and growth-stage companies through PM Equity Partner (PMEP), PMI’s corporate venture capital arm. This allocation follows a 2016 commitment of USD 150 million that PMEP has since fully invested and is intended to support PMI’s smoke-free and beyond nicotine ambitions.

With this latest round of funding, PMI will leverage its strengths to help investee companies translate innovation into commercial success. Developed through PMI’s journey to replace cigarettes with smoke-free alternatives, the company’s best-in-class capabilities include advanced life science expertise, preclinical and clinical research, and aerosolization.

PMEP is focusing its investment activities on four distinct technology segments:

  1. Life science innovations, such as inhaled therapeutics and computational research methodologies.
  2. Industrial technologies like industrial robotics and automation, the internet of things, and technology-based process optimization.
  3. Product technologies, particularly those that relate to inhalation and aerosolization, chemical formulation, and bio-authentication.
  4. Consumer engagement technologies, such as user identification and age authentication, innovative customer care, and experience management.

Emmanuel Babeau, PMI’s Chief Financial Officer, said: “PMI’s scientific and technological leadership has enabled us to re-invent our company in our pursuit to unsmoke the world. We are dedicating further funds to our venture capital arm at a moment when we are in an even stronger position to leverage our expertise to support the development and commercialization of cutting-edge technologies, to the benefit of both PMI and investee companies.”

Alexander Stoeckel, head of PMEP, added: “PMEP is looking to invest in companies that can help PMI accelerate and further sophisticate our transformation while we support them through our industry-leading expertise to mature their technologies and businesses. We see this exchange as a win-win for PMI, the companies we invest in, and society.”

PMEP has a track record of success with investments in 13 companies to date through its 2016 funding commitment. Ideal investments are between USD 2 to 10 million in Series A stage companies, with flexibility to also consider investments in seed or late-growth stage companies. PMEP investments are intended to add to our potential to innovate, while better positioning our partner companies for success.

PMI is leading the transformation of the industry in our pursuit to go smoke-free. Since 2008, we have invested more than USD 8.1 billion into the science and research of developing smoke-free products, employing hundreds of world-class scientists, engineers, and technicians in our R&D efforts. Our pre-clinical and clinical programs are inspired by the pharmaceutical industry and aligned with internationally recognized good practices, with more than 425 peer-reviewed publications and book chapters published since 2008. In July 2020, PMI was the second company to receive authorization from the U.S. FDA to market a nicotine or tobacco product as a modified risk tobacco product, with the agency concluding that issuing exposure modification orders for our heated tobacco system IQOS is “appropriate to promote the public health” and is “expected to benefit the health of the population as a whole.” Today, 29% of our total net revenues are derived from smoke-free products, and approximately 14.9 million adult smokers have switched to IQOS and stopped smoking.

More details on PMEP, its investment strategy, criteria, team, and how to be in touch can be found at www.pmequitypartner.com.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders, and other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, versions of PMI’s IQOS Platform 1 device and consumables have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI’s smoke-free product portfolio includes heat-not-burn products, nicotine-containing vapor products, and oral nicotine products. As of September 30, 2021, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 14.9 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

David Fraser
Philip Morris International
T. +41 (0)58 242 4500
E. david.fraser@pmi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Forty Years on From the Start of the HIV Epidemic, New Data Reveals People Living With HIV Face Outdated Attitudes and Ongoing Discrimination1.12.2021 03:01:00 EET | Press release

Pervasive stigma and prejudice towards people living with HIV continues to persist, according to a new international survey released today on World AIDS Day. Funded by ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline Plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, the survey uncovers outdated attitudes and inherent bias amongst the general public towards people living with HIV. An overwhelming majority (88%) of respondents believe there are still negative perceptions towards people living with HIV, even though it can now be effectively managed with antiretroviral (ARV) medication. Concerningly, almost a third (30%) of people surveyed incorrectly believe HIV can be transmitted through kissing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130006152/en/ The survey, conducted online by The Harris Poll, surveyed 5,047 adults across four countries, Australia, Portugal, U

Japan Domestic Flights Scheduled for Recovery in Q1 2022: Cirium Survey Reveals Sapporo and Okinawa as Top Destinations1.12.2021 03:00:00 EET | Press release

The majority of Japanese travelers intend to take to the skies again, with 80% planning to travel in the next 12 months for leisure purposes (83%) and to domestic destinations, according to the new Cirium Traveler Intelligence Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130006033/en/ Aviation analytics company Cirium records a noticeable increase in intention to travel across other markets surveyed, while travelers in Japan continue to be wary of the potential risks from COVID-19. International travel is likely to remain difficult, however, there are encouraging indicators of recovery in Japanese domestic markets. Cirium data shows domestic traffic in Japan at 54% of 2019 levels, above the 49% average seen across APAC domestic markets excluding China. Additionally, Cirium schedules data shows Japan is projected to reach 93% of 2019 Q1 traffic in the first quarter of 2022. The recovery of international flights c

Andersen Global Enters the Bolivian Market1.12.2021 02:16:00 EET | Press release

Andersen Global expands its Latin American coverage through a Collaboration Agreement with Bolivia-based law firm Indacochea & Asociados (IA) located in Santa Cruz de la Sierra. Founded in 1991, IA operates with six Partners and more than 40 professionals, offering full-service legal capabilities in arbitration, banking, corporate and commercial, civil law, dispute resolution, immigration, intellectual property, foreign investment, mergers and acquisitions, legal tech and startups, labor and real estate. The firm, consistently recognized by Chambers & Partners and the Legal 500, is led by Managing Partner Alonso Indacochea Pardo de Zela. “Our clients look to us to provide them with best-in-class service that enables them to succeed in today’s business environment. At IA, we changed the chip and became liquid lawyers, legal and business-oriented professionals with an open mindset to adaptability,” said Alonso. “Our collaboration with Andersen Global will allow us to offer our clients th

Schlumberger Announces Redemption of 100% of Outstanding 2.40% Senior Notes Due 20221.12.2021 01:00:00 EET | Press release

As part of its ongoing commitment to debt reduction, Schlumberger Limited (“Schlumberger”) today announced that Schlumberger Investment SA, an indirect wholly-owned subsidiary of Schlumberger (“SISA”), will redeem the entire outstanding principal amount of its 2.40% Senior Notes due 2022 (CUSIP Nos. 806854AD7 / L81445AD7; and ISIN Nos. US806854AD77 / USL81445AD75) (the “Notes”). The redemption date for the Notes is May 2, 2022 (the “Redemption Date”). The aggregate principal amount of the Notes outstanding is $1,000,000,000. SISA has deposited sufficient funds with The Bank of New York Mellon, the trustee under the indenture governing the Notes, to satisfy and discharge the Notes and the indenture with respect to the Notes (including payment of the February 1, 2022 interest payment with respect to the Notes and the redemption price payable on the Redemption Date), and the trustee has acknowledged such satisfaction and discharge. The Notes will be redeemed on the Redemption Date at a re

ITT’s Connector Business Introduces Veam MOVE-MOD™, Delivering True Modularity in Circular Interconnects30.11.2021 19:03:00 EET | Press release

November 30, 2021-- ITT Inc.’s (NYSE: ITT) connector business introduces its ruggedized, modular circular series Veam MOVE-MOD™. The flexible design delivers power, signal, and data in a single connector by utilizing a range of snap-in modules with various contact layouts to match individual system requirements. Developed for use in harsh environments, these ultra-durable connectors are suitable for a wide range of applications, including rail, heavy and off-road vehicles, alternative energy and infrastructure, robotics, and other industrial equipment. “Our customers have relied on Veam connectors to overcome their critical challenges for more than 60 years. MOVE-MOD is a next-generation solution designed to meet their evolving needs,” says Ellen McMillan, Vice President and General Manager Europe, ITT Connect and Control Technologies. “The modular nature of these innovative connectors give long-term flexibility to adapt, convert and expand connectivity post-design-in by simply swappin

Interactive Brokers Expands Tools for Global Investors30.11.2021 18:00:00 EET | Press release

Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, today introduced GlobalAnalyst, a new tool that lets investors compare the relative valuations and financial metrics of stocks globally. GlobalAnalyst is designed for investors interested in international portfolio diversification to discover undervalued companies that may have greater growth potential. Recognizing that it can be challenging for investors to evaluate the relative merits of stocks traded in different currencies, Interactive Brokers created a simple yet powerful tool to compare any number of stocks by various metrics in one of 27 currencies of the user’s choice. Similarly, users may buy and sell and follow these stocks in the currency of their choice, all in one account on one screen. Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to identify undervalued stocks worldwide. A table displays current market and various financial metrics, s

New 7197PCP-DIN-NX Controller Improves Operational Efficiency by Allowing Centralized Control of Volumetric Dispensing Pumps30.11.2021 17:15:00 EET | Press release

Nordson EFD , a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces the 7197PCP-DIN-NX controller for 797PCP progressive cavity pumps. This controller provides Ethernet connection with Transmission Control Protocol / Internet Protocol (TCP/IP) for Smart Factory and Industry 4.0 manufacturing integration. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005031/en/ Improve operational efficiency by programming 797PCP volumetric dispensing pumps directly from a PLC via 7197PCP-DIN-NX controllers. (Photo: Business Wire) “This is enabling technology that allows our customers to be more lean, more efficient, more productive and more versatile as we prepare to enter fourth industrial revolution,” said Claude Bergeron, Senior Product Line Manager, Nordson EFD. “By helping manufacturers prepare, we ensure they won’t get left behind as Smart Factories transfer significant value to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom